Victor D. Menashe v. Biogen Inc. et al

Track this case

Case overview

Case Number:

2:20-cv-10399

Court:

California Central

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

James V. Selna

Firms

Companies

Sectors & Industries:

  1. February 24, 2021

    Rosen to Rep Biogen Investors In Drug Trial Fraud Suit

    The Rosen Law Firm will represent a proposed class of investors in a suit alleging Biogen Inc. and three of its executives misrepresented the odds of approval for one of the pharmaceutical company's drugs with the U.S. Food and Drug Administration.

  2. January 13, 2021

    3 Firms Seek To Rep Biogen Investors In Securities Fraud Suit

    The Rosen Law Firm PA, Lowey Dannenberg PC and Pomerantz LLP all want to represent a proposed class of investors in a securities fraud suit in California federal court alleging Biogen Inc. and three of its executives misrepresented the odds of success that one of the pharmaceutical company's drugs has with the U.S. Food and Drug Administration.

  3. November 13, 2020

    Biogen Investors Say Co. Misled Them On Alzheimer's Drug

    Biogen Inc. investors on Friday hit the drugmaker with a putative class action claiming the company and its top brass misled shareholders about the effectiveness of aducanumab, a proposed drug for treating early Alzheimer's disease.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!